| Structure | Chemical Name | CAS | MF |
|
(4-Methoxy-phenyl)-morpholin-4-yl-acetonitrile hydrochloride
|
1129307-07-8
|
C13H17ClN2O2
|
|
9H-Carbazole, 9-[1,1':4',1''-terphenyl]-4-yl-
|
1129403-30-0
|
C30H21N
|
|
BBI-503(BB-503)
|
1129403-56-0
|
C31H33N5O2S
|
|
Pemetrexed-d5 Disodium Salt
|
1129408-57-6
|
C20H18N5Na2O6
|
|
SPIRO[3H-INDOLE-3,4'-PIPERIDINE]-1'-CARBOXYLIC ACID, 1,2-DIHYDRO-5-METHYL-, 1,1-DIMETHYLETHYL ESTER
|
1129411-47-7
|
C18H26N2O2
|
|
SPIRO[3H-INDOLE-3,4-PIPERIDINE]-1-CARBOXYLIC ACID, 1,2-DIHYDRO-4-(TRIFLUOROMETHYL)-, 1,1-DIMETHYLETHYL ESTER
|
1129421-52-8
|
C18H23F3N2O2
|
|
tert-Butyl 4-chloro-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate
|
1129432-44-5
|
C17H23ClN2O2
|
|
Conivaptan impurity
|
1129433-63-1
|
C32H26N4O2
|
|
IMMunoglobulin G2
|
1129435-60-4
|
|
|
1-Difluoromethyl-2-Oxo-1,2-Dihydro-Pyridine-3-Carboxylic Acid
|
1129458-32-7
|
C7H5F2NO3
|
|
(2S)-2-[[1,1,2,2-tetradeuterio-2-[[(2S)-1-hydroxybutan-2-yl]amino]ethyl]amino]butan-1-ol
|
1129526-19-7
|
C10H22D4Cl2N2O2
|
|
EthaMbutol-d8
|
1129526-23-3
|
C10H24N2O2
|
|
ethylene-d4)
|
1129526-24-4
|
C10H24N2O2
|
|
PACLITAXEL-D5
|
1129540-33-5
|
C47H46D5NO14
|
|
2-BroMo-6-Morpholinobenzonitrile
|
1129540-65-3
|
C11H11BrN2O
|
|
3-BROMO-1-(4-NITROPHENYL)-1H-1,2,4-TRIAZOLE
|
1129540-71-1
|
C8H5BrN4O2
|
|
1-(4-AMINO-PHENYL)-3-BROMO-1,2,4-TRIAZOLE
|
1129540-72-2
|
C8H7BrN4
|
|
3-broMo-5-Morpholinobenzonitrile
|
1129540-92-6
|
C11H11BrN2O
|
|
3-amino-1-methyl-1H-pyrazole-5-carboxamide
|
1129541-01-0
|
C5H8N4O
|
|
4-(3-fluoro-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)Morpholine
|
1129541-03-2
|
C16H23BFNO3
|
|
3-morpholino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
|
1129541-04-3
|
C17H23BN2O3
|
|
4-(3-(2-chloropyriMidin-4-yl)-5-fluorophenyl)Morpholine
|
1129541-05-4
|
C14H13ClFN3O
|
|
1-Bromo-3-fluoro-5-(trifluoromethoxy)benzene
|
1129541-09-8
|
C7H3BrF4O
|
|
4-(3-Bromo-5-fluorophenyl)morpholine
|
1129541-62-3
|
C10H11BrFNO
|
|
tert-Butyl 4-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
|
1129541-83-8
|
C21H32BFN2O4
|
|
tert-butyl 4-(3-cyano-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
|
1129541-91-8
|
C22H32BN3O4
|
|
3-broMo-5-fluoro-N,N-diMethylaniline
|
1129542-02-4
|
C8H9BrFN
|
|
3-fluoro-N,N-diMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)aniline
|
1129542-03-5
|
C14H21BFNO2
|
|
HYPOCRETIN (70-98) (HUMAN)
|
1129545-33-0
|
C125H214N44O37S
|
|
(S)-5-tert-butyl 6-methyl 5-azaspiro[2.4]heptane-5,6-dicarboxylate
|
1129634-43-0
|
C13H21NO4
|
|
(S)-5-BOC-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID
|
1129634-44-1
|
C12H19NO4
|
|
IM-12
|
1129669-05-1
|
C22H20FN3O2
|
|
Tandospirone impurity 6
|
1129675-92-8
|
C21H27N5O2
|
|
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-(4-hydroxyphenyl)urea
|
1129683-83-5
|
C14H10ClF3N2O2
|
|
TICAGRELOR
|
1129683-88-0
|
C14H14N4O3
|
|
2-epi-Fagomine
|
1129725-67-2
|
C6H13NO3
|
|
1,2,3,5,6-Penta-O-tert-butyldimethylsilyl-α-D-galactofuranose
|
1130008-07-9
|
C36H82O6Si5
|
|
CIPROFLOXACIN-D8
|
1130050-35-9
|
C17H18FN3O3
|
|
Morpholine, 2,5-diMethyl-, (2R,5S)-
|
1130053-86-9
|
C6H13NO
|
|
Morpholine, 2,5-diMethyl-, (2R,5R)-
|
1130061-44-7
|
C6H13NO
|
|
N-[(1S)-2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl-2-naphthalenecarboxamide
|
1130067-06-9
|
C26H27CIN4O2.HCl
|
|
N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide
|
1130067-18-3
|
C25H26N4O2
|
|
(2S)-2-amino-2-cyclopropylpropanoic acid
|
1130070-43-7
|
C6H11NO2
|
|
a-Cyclopropyl-Ala-OH·HCl
|
1130070-45-9
|
C6H11NO2
|
|
Iclaprim-d6
|
1130072-57-9
|
C19H22N4O3
|
|
Donafenib
|
1130115-44-4
|
C21H16ClF3N4O3
|
|
4-Piperidinol, 1-[4-amino-3-(1-methylethoxy)phenyl]-
|
1130146-81-4
|
C14H22N2O2
|
|
1-(4-aMino-3-ethoxyphenyl)piperidin-4-ol
|
1130146-98-3
|
C13H20N2O2
|
|
(E)-4-(diMethylaMino)but-2-enoic acid (Hydrochloride)
|
1130155-48-4
|
C6H12ClNO2
|
|
tert-butyl 3-hydroxy-4-oxopiperidine-1-carboxylate
|
1130156-23-8
|
C10H17NO4
|
|
7-tert-butyl 3-ethyl 2-aMino-5,6-dihydro-4H-thieno[2,3-c]azepine-3,7(8H)-dicarboxylate
|
1130156-84-1
|
C16H24N2O4S
|
|
Sorafenib β-D-Glucuronide
|
1130164-93-0
|
C27H24ClF3N4O9
|
|
4-BROMO-3-FLUOROBENZOIC ACID ETHYL ESTER
|
1130165-74-0
|
C9H8BrFO2
|
|
heptafluthrin
|
1130296-65-9
|
C18H17F7O3
|
|
BUTYL 4-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-6,8-DIFLUOROQUINOLINE-2-CARBOXYLATE
|
1130309-31-7
|
C23H29F2N3O4
|
|
2-(1-Methyl-1H-indazol-5-yl)ethanaMine
|
1130309-67-9
|
C10H13N3
|
|
1H-Pyrazolo[4,3-b]pyridine, 7-Methyl-
|
1130309-70-4
|
C7H7N3
|
|
Methyl 2,6-dichloro-4-(trifluoromethyl)nicotinate
|
1130344-76-1
|
C8H4Cl2F3NO2
|
|
3-broMo-4,5-dihydroisoxazole-5-carboxylic acid
|
1130365-33-1
|
C4H4BrNO3
|
|
1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trimethylsilyl)-1H-1,2,3-triazole
|
1130489-19-8
|
C18H28BN3O2Si
|
|
4,4,5,5-tetramethyl-2-(1,2,3,4-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane
|
1130490-92-4
|
C16H23BO2
|
|
Hydroxy Darunavir
|
1130635-75-4
|
C27H37N3O8S
|
|
5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE
|
1130759-48-6
|
C10H14BrN3
|
|
1-(5-bromopyridin-3-yl)-4-methylpiperazine
|
1130759-48-6
|
C10H14BrN3
|
|
(4'-CYANO-[1,1'-BIPHENYL]-3-YL)BORONIC ACID
|
1130760-55-2
|
C13H10BNO2
|
|
Superstable Pd(0) catalyst
|
1130784-80-3
|
C72H27F54P3Pd
|
|
7-Bromo-[1,2,3,4]tetrazolo[1,5-a]pyridine
|
1130816-25-9
|
C5H3BrN4
|
|
Ibadronic Acid-d3
|
1130899-41-0
|
C9H23NO7P2
|
|
Arbidol O-Glucuronide
|
1130900-96-7
|
C28H33BrN2O9S
|
|
Arbidol Impurity 1
|
1130901-04-0
|
C21H23BrN2O3S
|
|
Allisartan Isoproxil Impurity 5
|
1131003-59-2
|
C31H37ClN6O5
|
|
6-(difluoroMethoxy)pyridin-2-aMine
|
1131007-43-6
|
C6H6F2N2O
|
|
6-(trifluoroMethoxy)pyridin-2-aMine
|
1131007-45-8
|
C6H5F3N2O
|
|
FATPA , 4,4,8,8,-12,12-hexa-p-tolyl-4H-8H-12H-12C-aza-dibenzo[
|
1131007-94-7
|
C63H51N
|
|
Kaempferol 3,4‘-diglucoside 7-rhamnoside
|
1131009-93-2
|
C33H40O20
|
|
ethyl 2-broMo-3-fluorobenzoate
|
1131040-49-7
|
C9H8BrFO2
|
|
[3-(2,5-dioxo-2,5-dihydro-pyrrol-1-y1)-propyl]-carbaMic acid tert-butyl ester
|
1131041-38-7
|
C12H18N2O4
|
|
1H-Pyrazolo[3,4-b]pyrazine, 3-methyl-
|
1131041-58-1
|
C6H6N4
|
|
5-bromo-6-chloro-2-nitro-3-Pyridinol
|
1131041-71-8
|
C5H2BrClN2O3
|
|
2-AMino-5-broMo-6-chloropyridin-3-ol
|
1131041-72-9
|
C5H4BrClN2O
|
|
tert-butyl 5-bromo-6-chloro-3-hydroxypyridin-2-ylcarbamate
|
1131041-73-0
|
C10H12BrClN2O3
|
|
tert-butyl 3-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine-1-carboxylate
|
1131121-50-0
|
C18H26BN3O4
|
|
(S)-2-(4-bromophenyl)morpholine hydrochloride
|
1131220-34-2
|
C10H13BrClNO
|
|
(2S)-2-(4-Bromo-phenyl)-morpholine-4-carboxylic acid tert-butyl ester
|
1131220-37-5
|
C15H20BrNO3
|
|
tert-butyl 2-(4-bromophenyl)morpholine-4-carboxylate
|
1131220-82-0
|
C15H20BrNO3
|
|
tert-butyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine-4-carboxylate
|
1131220-85-3
|
C21H32BNO5
|
|
2-Methyl-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-isoquinolin-1-one
|
1131223-44-3
|
C16H22BNO3
|
|
tert-Butyl 5-methoxypyridin-3-yl carbonate
|
1131335-38-0
|
C11H15NO4
|
|
2-Bromo-5-iodo-3-methoxypyridine
|
1131335-43-7
|
C6H5BrINO
|
|
2,6-Diiodo-3,5-dimethoxypyridine
|
1131335-49-3
|
C7H7I2NO2
|
|
2,3-Dimethoxy-6-(trimethylsilyl)pyridine
|
1131335-54-0
|
C10H17NO2Si
|
|
2,3-Dimethoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
|
1131335-62-0
|
C13H20BNO4
|
|
(6-Bromofuro[3,2-b]pyridin-2-yl)methanol
|
1131335-66-4
|
C8H6BrNO2
|
|
6-Iodofuro[3,2-b]pyridine
|
1131335-68-6
|
C7H4INO
|
|
6-Bromo-2-(trimethylsilyl)furo[3,2-b]pyridine
|
1131335-72-2
|
C10H12BrNOSi
|
|
2,3-Dimethoxy-5-(trimethylsilyl)pyridine
|
1131335-75-5
|
C10H17NO2Si
|
|
JWJOTENAMICLJG-XHGXNVPLSA-N
|
1131341-46-2
|
C27H30F6N2O2
|
|
FINASTERIDE-D9
|
1131342-85-2
|
C23H27D9N2O2
|
|
Etoricoxib D4
|
1131345-14-6
|
C18H11ClD4N2O2S
|
|
3-Chloro-5-fluorobenzene-1-sulfonyl chloride
|
1131397-73-3
|
C6H3Cl2FO2S
|